MTMR9
Basic information
Region (hg38): 8:11284816-11328146
Previous symbols: [ "C8orf9", "MTMR8" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTMR9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 42 | 47 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 42 | 3 | 4 |
Variants in MTMR9
This is a list of pathogenic ClinVar variants found in the MTMR9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-11284947-C-A | not specified | Uncertain significance (Jun 07, 2023) | ||
8-11285001-T-C | not specified | Uncertain significance (Feb 06, 2024) | ||
8-11285057-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
8-11295246-A-T | not specified | Uncertain significance (May 08, 2023) | ||
8-11295251-G-T | not specified | Uncertain significance (May 13, 2024) | ||
8-11295294-T-A | not specified | Uncertain significance (Jul 29, 2023) | ||
8-11300030-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
8-11300035-C-G | not specified | Uncertain significance (Apr 06, 2023) | ||
8-11300038-G-C | not specified | Uncertain significance (Dec 06, 2022) | ||
8-11300059-C-G | not specified | Uncertain significance (Jan 26, 2022) | ||
8-11300072-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
8-11300087-T-G | not specified | Uncertain significance (Feb 28, 2023) | ||
8-11300096-A-G | not specified | Uncertain significance (Aug 08, 2022) | ||
8-11300105-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
8-11300108-C-G | Benign (Jun 26, 2018) | |||
8-11300138-A-C | not specified | Uncertain significance (Dec 15, 2022) | ||
8-11304848-A-C | not specified | Uncertain significance (Aug 26, 2022) | ||
8-11304863-A-C | not specified | Uncertain significance (Jun 27, 2022) | ||
8-11304883-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
8-11304889-C-G | Likely benign (Dec 01, 2022) | |||
8-11304968-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
8-11304987-A-C | Benign (Mar 10, 2022) | |||
8-11306250-G-C | not specified | Uncertain significance (Nov 14, 2023) | ||
8-11306308-G-A | not specified | Uncertain significance (Aug 15, 2023) | ||
8-11306311-C-G | not specified | Uncertain significance (Mar 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTMR9 | protein_coding | protein_coding | ENST00000221086 | 10 | 43722 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00126 | 0.999 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.33 | 418 | 304 | 1.38 | 0.0000157 | 3605 |
Missense in Polyphen | 80 | 86.318 | 0.9268 | 990 | ||
Synonymous | -4.01 | 167 | 113 | 1.48 | 0.00000586 | 1035 |
Loss of Function | 3.46 | 11 | 32.2 | 0.341 | 0.00000184 | 329 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000121 | 0.000121 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000707 | 0.0000703 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable pseudophosphatase. Contains a Gly residue instead of a conserved Cys residue in the dsPTPase catalytic loop which renders it catalytically inactive as a phosphatase (Potential). {ECO:0000305}.;
- Pathway
- Metabolism of lipids;Metabolism;Inositol phosphate metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the late endosome membrane;PI Metabolism;Phospholipid metabolism;Synthesis of IP2, IP, and Ins in the cytosol
(Consensus)
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- loftool
- 0.0637
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.94
Haploinsufficiency Scores
- pHI
- 0.0965
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.622
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.882
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mtmr9
- Phenotype
Gene ontology
- Biological process
- phosphatidylinositol biosynthetic process;negative regulation of autophagy;positive regulation of phosphatase activity;dephosphorylation;protein stabilization;regulation of phosphatidylinositol dephosphorylation
- Cellular component
- cytoplasm;cytosol;protein-containing complex
- Molecular function
- phosphatidylinositol-3-phosphatase activity;protein binding;protein phosphatase binding;enzyme regulator activity;phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity